You are here: Home » Current Affairs » Coronavirus » News
Business Standard

China joins WHO-led COVAX for equitable access to Covid-19 vaccines

China said on Friday that it has joined the WHO-led COVAX international initiative which aims to ensure equitable global access to vaccines against the novel coronavirus

Coronavirus Vaccine | China | Coronavirus

IANS  |  Beijing 

Coronavirus, vaccine, covid
File Photo

said on Friday that it has joined the World Health Organization (WHO)-led COVAX international initiative which aims to ensure equitable global access to vaccines against the novel .

said it joined the global initiative to make its vaccines a global good and make them available to developing countries on a priority.

"Even when is leading the world with several vaccines in advanced stages of R&D and with ample production capacity, it still decided to join COVAX," said China's Foreign Ministry spokesperson Hua Chunying.

"To that end, we have solemnly pledged to make #vaccines developed and deployed by China a global public good, which will be provided to developing countries as a priority, she said.

COVAX has been created to maximise the chances of successfully developing COVID-19 vaccines and manufacture them in the quantities needed to end this crisis.

Coordinated by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and the WHO, COVAX aims to have two billion doses of Covid-19 available by the end of 2021, which should be enough to protect high risk and vulnerable people, as well as frontline healthcare workers.

"China will also strengthen vaccine cooperation with relevant countries through the COVAX network," the Chinese Foreign Ministry spokesperson said.

China joining the network will be huge boost to the initiative as the US had earlier said it would not participate in the scheme.

Along with US and Russia, China was absent from list of 156 countries that signed up by September 18 deadline to join the COVID-19 vaccine allocation plan, South China Morning Post reported.



(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, October 09 2020. 14:54 IST